CDK5 inhibition in vitro and in vivo induces cell death in myeloma and overcomes the obstacle of bortezomib resistance
Affiliations: Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Public Health Sciences, University of Rochester, Rochester, NY 14642, USA, Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
- Published online on: March 26, 2020 https://doi.org/10.3892/ijmm.2020.4553
Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.